LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Home・Aktien・Aytu BioScience Inc

Aytu BioScience Inc

Open

2.24

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.23

Max

2.27

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+253.98 upside

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

2.45 / 2.5 Unterstützung & Widerstand

Aytu BioScience Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Okt. 2024, 22:33 UTC

Top News

New Zealand's Inflation Back Within Band; RBNZ Set to Continue Slashing Rates

15. Okt. 2024, 21:35 UTC

Wichtige Markttreiber

Novocure Shares Rise After FDA Approves Optune Lua Cancer Treatment

15. Okt. 2024, 19:26 UTC

Ergebnisse

Trending: Johnson & Johnson Posts Higher-Than-Expected Sales

15. Okt. 2024, 19:24 UTC

Wichtige Markttreiber

Oklo Shares Climb 22% After DOE Approves Fuel Fabrication Facility Concept

15. Okt. 2024, 18:40 UTC

Wichtige Markttreiber

Montrose Environmental Shares Up 17% After Securing $249 Million U.S. Army Contract

15. Okt. 2024, 18:24 UTC

Top News

Louis Vuitton Owner LVMH Misses Third-Quarter Revenue Expectations Amid Luxury Slowdown -- 2nd Update

15. Okt. 2024, 17:32 UTC

Ergebnisse

Adidas Raises Full-Year Guidance on Brand Momentum, Third-Quarter Results -- Update

15. Okt. 2024, 23:48 UTC

Market Talk

Gold Steady Ahead of Major U.S. Economic Data, Fed Official's Speech -- Market Talk

15. Okt. 2024, 22:54 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire's Move to Sell Apple Doesn't Look Good. It May Have Left $25 Billion on the Table. -- Barrons.com

15. Okt. 2024, 22:45 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire's Move to Sell Apple Doesn't Look Good. It May Have Left $25 Billion on the Table. -- Barrons.com

15. Okt. 2024, 21:33 UTC

Ergebnisse

Schwab's Latest Earnings Are a Turning Point for the Beleaguered Stock. 4 Big Takeaways. -- Barrons.com

15. Okt. 2024, 21:08 UTC

Top News

Boeing, Needing Cash, Moves to Sell New Shares -- 2nd Update

15. Okt. 2024, 20:56 UTC

Top News

Ergebnisse

Morgan Stanley Earnings Expected to Ride Investment Banking Wave -- Barrons.com

15. Okt. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

15. Okt. 2024, 20:50 UTC

Market Talk

Ergebnisse

Health Care Roundup: Market Talk

15. Okt. 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. Okt. 2024, 20:38 UTC

Ergebnisse

Nvidia Stock Falls After ASML Earnings Leak Early. Why the Drop Is an Overreaction. -- Barrons.com

15. Okt. 2024, 20:20 UTC

Ergebnisse

Interactive Brokers Slides On Earnings Miss. Charles Schwab Ends Streak Of Losses. -- IBD

15. Okt. 2024, 20:18 UTC

Top News

Slump in Chip Stocks Weighs on Indexes -- WSJ

15. Okt. 2024, 19:41 UTC

Ergebnisse

Bank of America Bond Losses Narrowed to $85.7 Billion. They Still Lead the Industry. -- Barrons.com

15. Okt. 2024, 19:30 UTC

Market Talk

Oil Futures Drop As Fear of Supply Disruption Eases -- Market Talk

15. Okt. 2024, 19:19 UTC

Market Talk

U.S. Natural Gas Futures Strive to Hold $2.50 -- Market Talk

15. Okt. 2024, 19:14 UTC

Market Talk

Gold Rises as Equity Markets Slip -- Market Talk

15. Okt. 2024, 18:53 UTC

Market Talk

Card Activity Shows Four Retailers Topping 3Q Forecasts -- Market Talk

15. Okt. 2024, 18:43 UTC

Market Talk

Ergebnisse

LVMH Sounds Caution On Recovery In U.S. Luxury Goods Market -- Market Talk

15. Okt. 2024, 18:04 UTC

Top News

Ergebnisse

Three Big Takeaways From Bank Earnings -- WSJ

15. Okt. 2024, 18:04 UTC

Top News

Investors Weigh Earnings From Goldman, Citi and BofA -- WSJ

15. Okt. 2024, 17:56 UTC

Ergebnisse

Nvidia Stock Falls After ASML Earnings Leak Early. Why the Drop Is an Overreaction. -- Barrons.com

15. Okt. 2024, 17:51 UTC

Ergebnisse

Merrill Lynch Client Assets Spike 18% to $3.5 Trillion -- Barrons.com

15. Okt. 2024, 17:51 UTC

Ergebnisse

Nvidia Stock Falls After ASML Earnings Leak Early. Why the Drop Is an Overreaction. -- Barrons.com

Peer-Vergleich

Kursveränderung

Aytu BioScience Inc Prognose

Kursziel

By TipRanks

253.98% Vorteil

12-Monats-Prognose

Durchschnitt 8 USD 253.98%

Hoch 8 USD

Tief 8 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Aytu BioScience Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Aytu BioScience Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

2.45 / 2.5Unterstützung & Widerstand

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

916.07

↓-0.02%

UNH

UnitedHealth Group Inc

566.13

↓-0.87%

NVO

Novo Nordisk A-S

118.17

↑ +0.23%

JNJ

Johnson and Johnson

164.55

↑ +0.16%

ABBV

AbbVie Inc

188.57

↓-1%

Aytu BioScience Inc

Übersicht

Veränderung der Aktienkurses

Empfehlungen

Technischer Score

Aytu BioScience Inc Chart

Ähnliche Nachrichten

Peer-Vergleich

Aytu BioScience Inc Prognose

Kursziel

Rating-Konsens

Technischer Score

Andere Aktien aus dem Sektor

Crucial information about Facebook accounts